Facilitators and barriers to exercise in autoimmune myasthenia gravis: A cross-sectional survey study
Journal of Neuromuscular Diseases · 25.06.2026
DOI: 10.1177/22143602261463887 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift Journal of Neuromuscular Diseases, online erschienen am 25.06.2026. Verfasst von Simone Birnbaum und 4 weiteren Autor:innen. Beteiligte Einrichtung: Neuromuscular Investigation Center, Neuromuscular Physiology and Evaluation Laboratory, Groupe Hospitalier Pitié Salpêtrière, Institute of Myology, P…. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: AFM-Téléthon.
Abstract (Originalsprache)
Introduction
Knowledge about facilitators and barriers to exercise among individuals with MG is limited.
Objective
The aim of this study was to identify factors that influence exercise participation for adults with MG and to explore beliefs and perceptions with respect to exercise.
Methods
This was a cross-sectional observational study via an online questionnaire. Adults with MG residing in France were eligible.
Results
Responses from 455 participants were analysed. The majority were between 50 and 69 years, 71% were female, 80% had generalised MG, and half had early-onset MG. Participants reported reduced MG-specific QoL (MGQOL-15F-r), a moderate-to-high impact of MG on activities of daily living (MG-ADL), and mild-to-moderate fatigue levels (NeuroQoL fatigue). Overall, 54% of respondents reported engaging in exercise (“exercisers”), while 47% did not (“non-exercisers”). Exercisers had a lower BMI, reported less fatigue, better HRQoL and a lower impact of MG on ADLs compared to non-exercisers. Fear of exercising was reported by one-third of participants, including half of non-exercisers versus 19% of exercisers (p < 0.001). Non-exercisers reported significantly more barriers to exercise (mean 3.5 (1.8)) than exercisers (mean 2.6 (1.9), p < 0.001). Health/symptoms was the most frequently reported barrier in both groups (59% of non-exercisers, 39% of exercisers). Non-exercisers also reported fewer facilitators (mean 2.1 (1.4)) than for exercisers (mean 2.5 (1.3), p=0.004). The most frequently cited facilitator for non-exercisers was specialised supervision/coaching (59%), while exercisers most frequently cited health/symptom improvement (57%).
Conclusion
Several barriers and facilitators influencing exercise participation for individuals with MG could be addressed with tailored programmes.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Neuromuscular Investigation Center, Neuromuscular Physiology and Evaluation Laboratory, Groupe Hospitalier Pitié Salpêtrière, Institute of Myology, Paris, France.
- Patient expert and representative advocacy and support group myasthenic syndromes, AFM-Téléthon, Evry, France.
- Direction des Opérations et Innovations Scientifiques (DO.IS), Département Data Santé et Recherche Médicale (DSRM), AFM-Téléthon, Evry, France.
ORCID-Profile: Simone Birnbaum
Förderung
- AFM-Téléthon
Zitieren
APA
Birnbaum, S., Archer, A., Lejeune, J., Hogrel, J. Y., & Stalens, C. (2026). Facilitators and barriers to exercise in autoimmune myasthenia gravis: A cross-sectional survey study. Journal of Neuromuscular Diseases. https://doi.org/10.1177/22143602261463887
Vancouver
Birnbaum S, Archer A, Lejeune J, Hogrel JY, Stalens C. Facilitators and barriers to exercise in autoimmune myasthenia gravis: A cross-sectional survey study. Journal of Neuromuscular Diseases. 2026. doi:10.1177/22143602261463887
BibTeX
@article{Birnbaum2026,
author = {Birnbaum, Simone and Archer, Annie and Lejeune, Julie and Hogrel, Jean-Yves and Stalens, Caroline},
title = {Facilitators and barriers to exercise in autoimmune myasthenia gravis: A cross-sectional survey study},
journal = {Journal of Neuromuscular Diseases},
year = {2026},
doi = {10.1177/22143602261463887}
}
EUVIMED